PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21213107-2	2011	As the genetically polymorphic cytochrome P450 (CYP), enzyme CYP2C9 is mainly responsible for the hepatic metabolism of sulfonylureas (SUs), we hypothesized that the slow-metabolizer genotypes *2/*2, *2/*3, and *3/*3 might be overrepresented in type 2 diabetic patients with SH.	Sulfonylurea Compounds	120-133	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	61-67	
21213107-2	2011	As the genetically polymorphic cytochrome P450 (CYP), enzyme CYP2C9 is mainly responsible for the hepatic metabolism of sulfonylureas (SUs), we hypothesized that the slow-metabolizer genotypes *2/*2, *2/*3, and *3/*3 might be overrepresented in type 2 diabetic patients with SH.	Sulfonylurea Compounds	135-138	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	61-67	
21213107-9	2011	However, in the control group, patients with CYP2C9 genotypes, predicting slower metabolism of SU drugs, were treated with significantly lower doses (p = 0.027) than were extensive metabolizers, whereas in the patient group with severe hypoglycemia, the dose was the same for all genotype groups.	Sulfonylurea Compounds	95-97	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	45-51